Skip to main content
Top
Published in: International Urology and Nephrology 2/2024

Open Access 09-08-2023 | Chronic Kidney Disease | Nephrology - Original Paper

Prevalence and associated factors of frailty in patients with chronic kidney disease: a cross-sectional analysis of PEAKING study

Authors: Changyuan Yang, Cuixia Xiao, Jiahao Zeng, Ruolan Duan, Xitao Ling, Jiamei Qiu, Qin Li, Xindong Qin, La Zhang, Jiasheng Huang, Jiawei He, Yifan Wu, Xusheng Liu, Haijing Hou, Bengt Lindholm, Fuhua Lu, Guobin Su

Published in: International Urology and Nephrology | Issue 2/2024

Login to get access

Abstract

Aim

 Frailty is common and is reported to be associated with adverse outcomes in patients with chronic diseases in Western countries. However, the prevalence of frailty remains unclear in individuals with chronic kidney disease (CKD) in China. We examined the prevalence of frailty and factors associated with frailty in patients with CKD.

Methods

 This was a cross-sectional analysis of 177 adult patients (mean age 54 ± 15 years, 52% men) with CKD from the open cohort entitled Physical Evaluation and Adverse outcomes for patients with chronic Kidney disease IN Guangdong (PEAKING). Frailty at baseline were assessed by FRAIL scale which included five items: fatigue, resistance, ambulation, illnesses, and loss of weight. Potential risk factors of frailty including age, sex, body mass index, and daily step counts recorded by ActiGraph GT3X + accelerometer were analyzed by multivariate logistic regression analysis.

Results

The prevalence of prefrailty and frailty was 50.0% and 11.9% in patients with stages 4–5 CKD, 29.6% and 9.3% in stage 3, and 32.1% and 0 in stages 1–2. In the multivariate logistic regression analysis, an increase of 100 steps per day (OR = 0.95, 95% CI 0.91–0.99, P = 0.01) and an increase of 5 units eGFR (OR = 0.82, 95% CI 0.68–0.99, P = 0.045) were inversely associated with being frail; higher BMI was associated with a higher likelihood of being frail (OR = 1.52, 95% CI 1.11–2.06, P = 0.008) and prefrail (OR = 1.25, 95% CI 1.10–1.42, P = 0.001).

Conclusion

 Frailty and prefrailty were common in patients with advanced CKD. A lower number of steps per day, lower eGFR, and a higher BMI were associated with frailty in this population.
Appendix
Available only for authorised users
Literature
1.
go back to reference Romagnani P, Remuzzi G, Glassock R et al (2017) Chronic kidney disease. Nat Rev Dis Prim 3(1):1–24 Romagnani P, Remuzzi G, Glassock R et al (2017) Chronic kidney disease. Nat Rev Dis Prim 3(1):1–24
2.
go back to reference Xie Y, Bowe B, Mokdad AH et al (2018) Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int 94(3):567–581CrossRefPubMed Xie Y, Bowe B, Mokdad AH et al (2018) Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int 94(3):567–581CrossRefPubMed
3.
go back to reference Morley JE, Vellas B, Abellan Van Kan G, et al (2013) Frailty consensus: a call to action. J Am Med Direct Assoc 14(6):392–397 Morley JE, Vellas B, Abellan Van Kan G, et al (2013) Frailty consensus: a call to action. J Am Med Direct Assoc 14(6):392–397
4.
go back to reference Chowdhury R, Peel NM, Krosch M, Hubbard RE (2017) Frailty and chronic kidney disease: a systematic review. Arch Gerontol Geriatr 68:135–142CrossRefPubMed Chowdhury R, Peel NM, Krosch M, Hubbard RE (2017) Frailty and chronic kidney disease: a systematic review. Arch Gerontol Geriatr 68:135–142CrossRefPubMed
6.
go back to reference Nixon AC, Bampouras TM, Pendleton N, Woywodt A, Mitra S, Dhaygude A (2018) Frailty and chronic kidney disease: current evidence and continuing uncertainties. Clin Kidney J 11(2):236–245CrossRefPubMed Nixon AC, Bampouras TM, Pendleton N, Woywodt A, Mitra S, Dhaygude A (2018) Frailty and chronic kidney disease: current evidence and continuing uncertainties. Clin Kidney J 11(2):236–245CrossRefPubMed
7.
go back to reference Johansen KL, Dalrymple LS, Glidden D et al (2016) Association of performance-based and self-reported function-based definitions of frailty with mortality among patients receiving hemodialysis. Clin J Am Soc Nephrol 11(4):626–632CrossRefPubMedPubMedCentral Johansen KL, Dalrymple LS, Glidden D et al (2016) Association of performance-based and self-reported function-based definitions of frailty with mortality among patients receiving hemodialysis. Clin J Am Soc Nephrol 11(4):626–632CrossRefPubMedPubMedCentral
8.
go back to reference Alfaadhel TA, Soroka SD, Kiberd BA, Landry D, Moorhouse P, Tennankore KK (2015) Frailty and mortality in dialysis: evaluation of a clinical frailty scale. Clin J Am Soc Nephrol 10(5):832–840CrossRefPubMedPubMedCentral Alfaadhel TA, Soroka SD, Kiberd BA, Landry D, Moorhouse P, Tennankore KK (2015) Frailty and mortality in dialysis: evaluation of a clinical frailty scale. Clin J Am Soc Nephrol 10(5):832–840CrossRefPubMedPubMedCentral
9.
go back to reference McAdams-DeMarco MA, Law A, Salter ML et al (2013) Frailty as a novel predictor of mortality and hospitalization in individuals of all ages undergoing hemodialysis. J Am Geriatr Soc 61(6):896–901CrossRefPubMedPubMedCentral McAdams-DeMarco MA, Law A, Salter ML et al (2013) Frailty as a novel predictor of mortality and hospitalization in individuals of all ages undergoing hemodialysis. J Am Geriatr Soc 61(6):896–901CrossRefPubMedPubMedCentral
10.
go back to reference Lee SY, Yang DH, Hwang E et al (2017) The prevalence, association, and clinical outcomes of frailty in maintenance dialysis patients. J Ren Nutr 27(2):106–112CrossRefPubMed Lee SY, Yang DH, Hwang E et al (2017) The prevalence, association, and clinical outcomes of frailty in maintenance dialysis patients. J Ren Nutr 27(2):106–112CrossRefPubMed
11.
go back to reference Hickson LJ, Thorsteinsdottir B, Ramar P et al (2018) Hospital readmission among new dialysis patients associated with young age and poor functional status. Nephron 139(1):1–12CrossRefPubMed Hickson LJ, Thorsteinsdottir B, Ramar P et al (2018) Hospital readmission among new dialysis patients associated with young age and poor functional status. Nephron 139(1):1–12CrossRefPubMed
12.
go back to reference Bao Y, Dalrymple L, Chertow GM, Kaysen GA, Johansen KL (2012) Frailty, dialysis initiation, and mortality in end-stage renal disease. Arch Intern Med 172(14):1071–1077CrossRefPubMedPubMedCentral Bao Y, Dalrymple L, Chertow GM, Kaysen GA, Johansen KL (2012) Frailty, dialysis initiation, and mortality in end-stage renal disease. Arch Intern Med 172(14):1071–1077CrossRefPubMedPubMedCentral
13.
go back to reference Roshanravan B, Khatri M, Robinson-Cohen C et al (2012) A prospective study of frailty in nephrology-referred patients with CKD. Am J Kidney Dis 60(6):912–921CrossRefPubMedPubMedCentral Roshanravan B, Khatri M, Robinson-Cohen C et al (2012) A prospective study of frailty in nephrology-referred patients with CKD. Am J Kidney Dis 60(6):912–921CrossRefPubMedPubMedCentral
14.
go back to reference Chao CT, Hsu YH, Chang PY et al (2015) Simple self-report FRAIL scale might be more closely associated with dialysis complications than other frailty screening instruments in rural chronic dialysis patients. Nephrology (Carlton) 20(5):321–328CrossRefPubMed Chao CT, Hsu YH, Chang PY et al (2015) Simple self-report FRAIL scale might be more closely associated with dialysis complications than other frailty screening instruments in rural chronic dialysis patients. Nephrology (Carlton) 20(5):321–328CrossRefPubMed
15.
go back to reference Kojima G (2018) Frailty defined by FRAIL scale as a predictor of mortality: a systematic review and meta-analysis. J Am Med Dir Assoc 19(6):480–483CrossRefPubMed Kojima G (2018) Frailty defined by FRAIL scale as a predictor of mortality: a systematic review and meta-analysis. J Am Med Dir Assoc 19(6):480–483CrossRefPubMed
16.
go back to reference Thompson MQ, Theou O, Tucker GR, Adams RJ, Visvanathan R (2020) FRAIL scale: predictive validity and diagnostic test accuracy. Australas J Ageing 39(4):e529–e536CrossRefPubMed Thompson MQ, Theou O, Tucker GR, Adams RJ, Visvanathan R (2020) FRAIL scale: predictive validity and diagnostic test accuracy. Australas J Ageing 39(4):e529–e536CrossRefPubMed
17.
go back to reference Aprahamian I, Cezar N, Izbicki R et al (2017) Screening for frailty with the FRAIL scale: a comparison with the phenotype criteria. J Am Med Dir Assoc 18(7):592–596CrossRefPubMed Aprahamian I, Cezar N, Izbicki R et al (2017) Screening for frailty with the FRAIL scale: a comparison with the phenotype criteria. J Am Med Dir Assoc 18(7):592–596CrossRefPubMed
18.
go back to reference Vandenbroucke JP, von Elm E, Altman DG et al (2007) Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Ann Intern Med 147(8):W163–W194CrossRefPubMed Vandenbroucke JP, von Elm E, Altman DG et al (2007) Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Ann Intern Med 147(8):W163–W194CrossRefPubMed
19.
go back to reference Inker LA, Astor BC, Fox CH et al (2014) KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis 63(5):713–735CrossRefPubMed Inker LA, Astor BC, Fox CH et al (2014) KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis 63(5):713–735CrossRefPubMed
20.
go back to reference Dent E, Morley JE, Cruz-Jentoft AJ et al (2019) Physical frailty: ICFSR international clinical practice guidelines for identification and management. J Nutr Health Aging 23(9):771–787CrossRefPubMedPubMedCentral Dent E, Morley JE, Cruz-Jentoft AJ et al (2019) Physical frailty: ICFSR international clinical practice guidelines for identification and management. J Nutr Health Aging 23(9):771–787CrossRefPubMedPubMedCentral
21.
go back to reference Ozturk S, Cetin DG, Cetin M et al (2022) Prevalence and associates of frailty status in different stages of chronic kidney disease: a cross-sectional study. J Nutr Health Aging 26(9):889–895CrossRefPubMed Ozturk S, Cetin DG, Cetin M et al (2022) Prevalence and associates of frailty status in different stages of chronic kidney disease: a cross-sectional study. J Nutr Health Aging 26(9):889–895CrossRefPubMed
22.
go back to reference Abellan VKG, Rolland Y, Bergman H, Morley JE, Kritchevsky SB, Vellas B (2008) The I.A.N.A Task Force on frailty assessment of older people in clinical practice. J Nutr Health Aging 12(1):29–37 Abellan VKG, Rolland Y, Bergman H, Morley JE, Kritchevsky SB, Vellas B (2008) The I.A.N.A Task Force on frailty assessment of older people in clinical practice. J Nutr Health Aging 12(1):29–37
23.
go back to reference Hemmelgarn BR, Manns BJ, Quan H, Ghali WA (2003) Adapting the Charlson Comorbidity Index for use in patients with ESRD. Am J Kidney Dis 42(1):125–132CrossRefPubMed Hemmelgarn BR, Manns BJ, Quan H, Ghali WA (2003) Adapting the Charlson Comorbidity Index for use in patients with ESRD. Am J Kidney Dis 42(1):125–132CrossRefPubMed
24.
go back to reference Weir CB, Jan A (2022) BMI classification percentile and cut off points. StatPearls, Treasure Island Weir CB, Jan A (2022) BMI classification percentile and cut off points. StatPearls, Treasure Island
26.
go back to reference LaMunion SR, Bassett DR, Toth LP, Crouter SE (2017) The effect of body placement site on ActiGraph wGT3X-BT activity counts. Biomed Phys Eng Exp 3(3):035026CrossRef LaMunion SR, Bassett DR, Toth LP, Crouter SE (2017) The effect of body placement site on ActiGraph wGT3X-BT activity counts. Biomed Phys Eng Exp 3(3):035026CrossRef
27.
go back to reference Heil DP, Brage S, Rothney MP (2012) Modeling physical activity outcomes from wearable monitors. Med Sci Sports Exerc 44(1 Suppl 1):S50-60CrossRefPubMed Heil DP, Brage S, Rothney MP (2012) Modeling physical activity outcomes from wearable monitors. Med Sci Sports Exerc 44(1 Suppl 1):S50-60CrossRefPubMed
28.
go back to reference Troiano RP, Berrigan D, Dodd KW, Mâsse LC, Tilert T, McDowell M (2008) Physical activity in the United States measured by accelerometer. Med Sci Sports Exerc 40(1):181–188CrossRefPubMed Troiano RP, Berrigan D, Dodd KW, Mâsse LC, Tilert T, McDowell M (2008) Physical activity in the United States measured by accelerometer. Med Sci Sports Exerc 40(1):181–188CrossRefPubMed
29.
go back to reference Inker LA, Eneanya ND, Coresh J et al (2021) New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med 385(19):1737–1749CrossRefPubMedPubMedCentral Inker LA, Eneanya ND, Coresh J et al (2021) New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med 385(19):1737–1749CrossRefPubMedPubMedCentral
30.
go back to reference Wilhelm-Leen ER, Hall YN, Tamura MK, Chertow GM (2009) Frailty and chronic kidney disease: the third national health and nutrition evaluation survey. Am J Med 122(7):664–71.e2CrossRefPubMedPubMedCentral Wilhelm-Leen ER, Hall YN, Tamura MK, Chertow GM (2009) Frailty and chronic kidney disease: the third national health and nutrition evaluation survey. Am J Med 122(7):664–71.e2CrossRefPubMedPubMedCentral
31.
go back to reference Zhu Z, Chen H, Ma J, He Y, Chen J, Sun J (2020) Exploring the relationship between walking and emotional health in China. Int J Environ Res Public Health 17(23):8804 Zhu Z, Chen H, Ma J, He Y, Chen J, Sun J (2020) Exploring the relationship between walking and emotional health in China. Int J Environ Res Public Health 17(23):8804
32.
go back to reference Seliger S, Weiner DE (2022) Exercise and kidney disease prevention: walk this way. Am J Kidney Dis 80(4):552–554CrossRefPubMed Seliger S, Weiner DE (2022) Exercise and kidney disease prevention: walk this way. Am J Kidney Dis 80(4):552–554CrossRefPubMed
33.
go back to reference Watanabe D, Yoshida T, Watanabe Y, Yamada Y, Kimura M, Group KKS (2020) Objectively measured daily step counts and prevalence of frailty in 3,616 older adults. J Am Geriatr Soc 68(10):2310–2318CrossRefPubMed Watanabe D, Yoshida T, Watanabe Y, Yamada Y, Kimura M, Group KKS (2020) Objectively measured daily step counts and prevalence of frailty in 3,616 older adults. J Am Geriatr Soc 68(10):2310–2318CrossRefPubMed
34.
go back to reference Yamada M, Nishiguchi S, Fukutani N, Aoyama T, Arai H (2015) Mail-based intervention for sarcopenia prevention increased anabolic hormone and skeletal muscle mass in community-dwelling Japanese older adults: the INE (Intervention by Nutrition and Exercise) study. J Am Med Dir Assoc 16(8):654–660CrossRefPubMed Yamada M, Nishiguchi S, Fukutani N, Aoyama T, Arai H (2015) Mail-based intervention for sarcopenia prevention increased anabolic hormone and skeletal muscle mass in community-dwelling Japanese older adults: the INE (Intervention by Nutrition and Exercise) study. J Am Med Dir Assoc 16(8):654–660CrossRefPubMed
35.
go back to reference Park H, Park S, Shephard RJ, Aoyagi Y (2010) Yearlong physical activity and sarcopenia in older adults: the Nakanojo Study. Eur J Appl Physiol 109(5):953–961CrossRefPubMed Park H, Park S, Shephard RJ, Aoyagi Y (2010) Yearlong physical activity and sarcopenia in older adults: the Nakanojo Study. Eur J Appl Physiol 109(5):953–961CrossRefPubMed
36.
37.
go back to reference Yuan L, Chang M, Wang J (2021) Abdominal obesity, body mass index and the risk of frailty in community-dwelling older adults: a systematic review and meta-analysis. Age Ageing 50(4):1118–1128CrossRefPubMed Yuan L, Chang M, Wang J (2021) Abdominal obesity, body mass index and the risk of frailty in community-dwelling older adults: a systematic review and meta-analysis. Age Ageing 50(4):1118–1128CrossRefPubMed
38.
go back to reference Lee SW, Lee A, Yu MY et al (2017) Is Frailty a modifiable risk factor of future adverse outcomes in elderly patients with incident end-stage renal disease? J Korean Med Sci 32(11):1800–1806CrossRefPubMedPubMedCentral Lee SW, Lee A, Yu MY et al (2017) Is Frailty a modifiable risk factor of future adverse outcomes in elderly patients with incident end-stage renal disease? J Korean Med Sci 32(11):1800–1806CrossRefPubMedPubMedCentral
39.
go back to reference Hiraki K, Yasuda T, Hotta C et al (2013) Decreased physical function in pre-dialysis patients with chronic kidney disease. Clin Exp Nephrol 17(2):225–231CrossRefPubMed Hiraki K, Yasuda T, Hotta C et al (2013) Decreased physical function in pre-dialysis patients with chronic kidney disease. Clin Exp Nephrol 17(2):225–231CrossRefPubMed
Metadata
Title
Prevalence and associated factors of frailty in patients with chronic kidney disease: a cross-sectional analysis of PEAKING study
Authors
Changyuan Yang
Cuixia Xiao
Jiahao Zeng
Ruolan Duan
Xitao Ling
Jiamei Qiu
Qin Li
Xindong Qin
La Zhang
Jiasheng Huang
Jiawei He
Yifan Wu
Xusheng Liu
Haijing Hou
Bengt Lindholm
Fuhua Lu
Guobin Su
Publication date
09-08-2023
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 2/2024
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-023-03720-z

Other articles of this Issue 2/2024

International Urology and Nephrology 2/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.